Current&Critical - Stephen Van Deventer, Cannabis&BioTech - An Insider's POV - a podcast by Tyler Chisholm

Investors investing in pharmaceuticals can be nervous about the lengthy process from R&D to commercialization and the regulatory approval processes. PreveCeuticals has diversified its research into four unique applications, which include three that have already been proven. Stephen took a bold approach of researching multiple solutions at once - something that can make investors feel a bit nervous. Stephen wants to develop treatments for major global medical issues like the opioid epidemic in Canada, and he knows exploring multiple projects at once is a faster way to do just that. Learn more about how to commercialize and invest in pharmaceuticals, particularly ‘fringe’ medicines such as cannabis.

Further episodes of Collisions YYC

Further podcasts by Tyler Chisholm

Website of Tyler Chisholm